These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31365803)

  • 21. Myxovirus resistance protein 1-expressing fatal myocarditis in a patient with anti-MDA5 antibody-positive dermatomyositis.
    Sakamoto R; Kotobuki Y; Iga S; Nojima S; Deno R; Hanaoka Y; Tonomura K; Kiyohara E; Nakagawa Y; Ueda-Hayakawa I; Arase N; Fujimoto M
    Rheumatology (Oxford); 2021 Dec; 60(12):e450-e452. PubMed ID: 34382080
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
    Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
    Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous ulceration and digital gangrene in an anti-MDA5-positive overlap myositis.
    Xu A; Lv X; Du F; Dai M
    Rheumatology (Oxford); 2021 Dec; 60(12):5880-5881. PubMed ID: 33752240
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
    De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
    Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
    Parperis K; Kiyani A
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seronegative dermatomyositis presenting with features of anti-MDA5 subtype.
    Ahmed A; Scarborough R; Gabriela R; Fernandez AP; Bergfeld W
    J Cutan Pathol; 2018 Nov; 45(11):851-854. PubMed ID: 30039536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease.
    Miyake M; Sakai A; Nishijima C; Kita T; Nitta E; Kawashima A; Hamaguchi Y; Fujimoto M; Inaoki M
    J Dermatol; 2014 Jul; 41(7):664-5. PubMed ID: 24930560
    [No Abstract]   [Full Text] [Related]  

  • 29. Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis.
    Rathore U; Haldule S; Gupta L
    Rheumatology (Oxford); 2021 Jul; 60(7):3483. PubMed ID: 33284978
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-MDA5 dermatomyositis mimicking psoriatic arthritis.
    Cabezas-Rodríguez I; Morante-Bolado I; Brandy-García A; Queiro-Silva R; Mozo L; Ballina-García FJ
    Reumatol Clin (Engl Ed); 2018; 14(4):224-226. PubMed ID: 28040421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N; Okamoto M; Kaieda S; Fujimoto K; Ebata T; Tajiri M; Nakamura M; Tominaga M; Wakasugi D; Kawayama T; Kuwana M; Mimori T; Ida H; Hoshino T
    Respir Investig; 2017 Jan; 55(1):24-32. PubMed ID: 28012490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral Eyelid Swelling as a Sign of Antimelanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Antibody-Positive Dermatomyositis.
    Lam SC; Yuen HKL
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):e209-e211. PubMed ID: 30365479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-MDA-5-positive dermatomyositis associated rapidly progressive interstitial lung disease, a virus-triggered autoimmune-like symptom?
    Xu L; Wang L; Lv C; Tan W
    Rheumatology (Oxford); 2021 Sep; 60(9):4428-4429. PubMed ID: 33752230
    [No Abstract]   [Full Text] [Related]  

  • 36. Eyelid edema as first manifestation of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease: A case report.
    Ludriksone L; Pfeil A; Schliemann S; Elsner P
    J Dtsch Dermatol Ges; 2020 Mar; 18(3):263-265. PubMed ID: 31922645
    [No Abstract]   [Full Text] [Related]  

  • 37. Unilateral heliotrope rash: a warning sign for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
    Kume M; Arase N; Okiyama N; Koguchi-Yoshioka H; Tada T; Saruban H; Fujimoto M
    Rheumatology (Oxford); 2021 Apr; 60(4):e134-e135. PubMed ID: 33197263
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful treatment with intravenous cyclophosphamide for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated with myelodysplastic syndrome.
    Nawata T; Kubo M; Okuda S; Omoto M; Yujiri T; Kanda T; Yano M
    Scand J Rheumatol; 2017 Nov; 46(6):496-498. PubMed ID: 27931156
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.
    Fujita Y; Fukui S; Suzuki T; Ishida M; Endo Y; Tsuji S; Takatani A; Igawa T; Shimizu T; Umeda M; Sumiyoshi R; Nishino A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Abe K; Kawakami A
    Intern Med; 2018 Dec; 57(23):3473-3478. PubMed ID: 29984753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihelix/helix violaceous macules in Japanese patients with anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis.
    Okiyama N; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Fujisawa Y; Watanabe R; Fujimoto M
    Br J Dermatol; 2019 May; 180(5):1226-1227. PubMed ID: 30431155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.